You may recall my “fools rush in” post last week on new-style health insurer Oscar’s $400 million dollar funding round. The company has acknowledged losing $105 million in New York and New Jersey in 2015. Yep, that wonderful new approach to health insurance is working great, but might want to get some actuaries to help out. As I said, fools rush in.
An evaluation of the concierge style primary care delivered by MDVIP finds the possibility of spending reductions.
Read More
CVS Health releases its initial 2015 Trend Report, suggesting that spending increases for medications have moderated.
Read More
A report published by the National Bureau of Economic Research finds that Americans are generally in good enough health to work longer.
Read More
McKesson, which owns large oncology practice US Oncology, is buying two more firms in the oncology space for $1.2 billion: Biologics, a cancer specialty pharmacy; and Vantage Oncology, a radiation and other therapy provider.
A study in JMIR-mHealth suggests wide dispersion in the ratings even by expert reviewers of the qualities of health apps.
Read More
Hearst Health Ventures has invested an undisclosed amount into Lightbeam Health Solutions, which collects and analyzes data to aid in identifying high cost patients or episodes.
http://medcitynews.com/2016/02/hearst-health-adds-population-health-to-portfolio/?utm_source=MedCity+News+Subscribers&utm_campaign=8ad03c0606-MCN+Daily+Email&utm_medium=email&utm_term=0_5092836c41-8ad03c0606-408793005&rf=1About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
Apple Podcasts
Google Podcasts
Spotify
Overcast
PocketCasts
Radio Public
Stitcher
Anchor
RSS - Posts